A Study To Evaluate Pregabalin In The Treatment Of Moderate To Severe Chronic Bone Pain Related To Metastatic Cancer

Clinical trial NCT00381095 · TERMINATED

Trial details

NCT number: NCT00381095
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Bone Neoplasms Pain, Intractable Cancer

Start date: 2006-12-01
Primary completion: 2010-10-01
Enrollment: 152

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.